About
Sponsors
Photos
Speakers
Edward Wood
CEO @ Northern Lights
As the CEO of Northern Lights, Edward Wood is responsible for running all facets of the business. He has a proven executive management track record and over 20 years of experience driving sales growth in the technology industry.
Elijah Lautner
CEO @ Luliz
Elijah is chief executive officer and a member of the company’s board of directors. He joined Luliz in 2010, bringing more than 30 years of technology industry leadership, computer hardware expertise, and executive management experience to his role with the company.
Alex Guillen
Ally Klein
P3 Student at Drake University
Ally Klein is an incoming P3 student at Drake University and an active Brother of the Psi Chapter. She has been a Brother of Phi Delta Chi since 2017 and held multiple positions in Psi's Chapter. She has held the positions of St. Jude Co-Chair, Worthy Vice Counselor, and will hold the position of Facilitator this upcoming year.
Ally conducts her research with Dr. Craige Wrenn, who is a current faculty member at Drake University. Her interests are in psychology and neuropharmacology, where her research and passion lies with studying Alzheimer's Disease. She has worked with Dr. Wrenn since the fall of 2019 on a project looking to help characterize the triple-transgenic mouse model of Alzheimer's Disease (3xTg-AD mouse model).
Alyssa Sykuta
PGY2 Critical Care Resident at Thomas Jefferson University Hospital
Alyssa Sykuta, PharmD, graduated from Drake University in 2019 where she was a member of the Psi chapter of Phi Delta Chi. She completed her PGY1 residency at the University of Iowa Hospitals & Clinics followed by a PGY2 in Critical Care at Thomas Jefferson University Hospital in Philadelphia, PA. Dr. Sykuta will soon be starting her post-residency career as a Critical Care Pharmacist at Johns Hopkins Hospital in Baltimore, MD. As a collegiate member of Phi Delta Chi, Dr. Sykuta served as Worthy Inner Guard. In 2021, she received the Distinguished Alumni Award from the Psi chapter.
Andrea Bourque
Angela Barnick
Angela Clauson
Director of Experiential Education; Associate Professor of Pharmacy Practice, Belmont University College of Pharmacy
Angela Clauson, Pharm.D. is the Director of Experiential Education and Associate Professor of Pharmacy Practice at Belmont University College of Pharmacy in Nashville, Tennessee. She currently serves as the faculty advisor to the Gamma Xi student chapter. Before coming to Belmont, she held the role of Assistant Professor of Pharmacy Practice at Palm Beach Atlantic University with an Ambulaotry Care Practice site serving the underserved at a Community Health Center. She also served as the Director of Experiential Education. She earned her Doctor of Pharmacy degree from the University of Tennessee-Memphis where she was a member of the Omega chapter. She completed her ASHP-acredited PGY1 residency at Advent Health Shawnee Mission (formerly called Shawnee Mission Medical Center) in Shawnee Mission, Kansas.
Anna Brecheisen
Any Jivan
PGY1 Managed Care Pharmacy Resident
I am an Arkansas native who graduated from The University of Texas at Austin College of Pharmacy in 2020. Through my time at UTCOP, I was and remain a proud Lambda Brother. I am currently a PGY1 Managed Care Pharmacy Resident at Kelsey-Seybold Clinic in Pearland, Texas. In my free time, I try to fly over to the west coast to see my husband and explore food and nature across the country (covid-permitting!).
Bailey Eason
Bianca Glab
Brenda Tran
Fourth Year Pharmacy Student and University of Colorado- Anschutz Medical Campus
I am Brenda Tran, a current fourth-year pharmacy student at the University of Colorado Anschutz Medical Campus. I am originally from Los Angeles, California. I received my bachelor’s degree in Biological Sciences at the University of California- Irvine with a minor in Business Management. I am interested in public health, patient education, and finding new responsibilities that pharmacists can partake in.
Brittany Parmentier
Clinical Assistant Professor, University of Texas at Tyler Fisch College of Pharmacy
Brittany Parmentier, PharmD, MPH, BCPS, BCPP, is a Clinical Assistant Professor in the Department of Clinical Sciences at The University of Texas at Tyler Fisch College of Pharmacy. Dr. Parmentier received her Doctor of Pharmacy degree from Drake University College of Pharmacy and Health Sciences in Des Moines, IA, and her Master of Public Health degree from Johns Hopkins University in Baltimore, MD.
After graduation from pharmacy school, Dr. Parmentier completed a PGY1 Pharmacy Practice Residency and a PGY2 Psychiatric Pharmacy Residency at Community Health Network and Butler University in Indianapolis, IN. She is a Board Certified Pharmacotherapy Specialist and a Board Certified Psychiatric Pharmacist. She practices as a clinical psychiatric pharmacist at UT Health East Texas in Tyler, TX, and precepts pharmacy students on an inpatient acute psychiatric elective APPE. She is currently the faculty advisor for the Delta Iota chapter.
Brooke Greene
Bryce Swift
Office Manager @ GenTr
Bryce Swift is an office manager and she cultivates the company culture and steers the ship in the right direction. Often the face of the office environment, she interacts with visitors, customers, clients, and employees at every level, every day.
Caitlin (Cait) Gibson
Through 6/18: Associate Professor and Vice Chair, University of North Texas System College of Pharmacy
Starting 8/16: Associate Professor, Virginia Commonwealth University
Dr. Gibson is a graduate of the University of Texas at Austin College of Pharmacy. She completed a PGY1 Pharmacy Residency at the Veterans Affairs North Texas Hospital in conjunction with Texas Tech University School of Pharmacy, and PGY2 Internal Medicine Residency at Indiana University Health in conjuncton with Butler University. She then worked as clinical faculty at the University of North Texas Health Science Center College of Pharmacy for seven years. She is currently enjoying a couple months off work, and will begin a clinical faculty Role at Virginia Commonwealth University in August 2021. Dr. Gibson is board certified in Pharmacotherapy and Cardiology, and her practice is in inpatient medicine and cardiology services. She also enjoys remaining involved in Phi Delta Chi, and has previously served as Worthy Vice Counselor at Lambda, Regional Director for Collegiate Affairs in the Southcentral Region, Chair of the Advisor Toolkit Committee, and Co-Chair of the Grand Council Continuing Education Subcommittee.
Candace Sutton
Clinical Staff Pharmacist at UT Southwestern Medical Center
Candace Sutton, PharmD is a 2013 graduate from Southwestern Oklahoma State University College of Pharmacy in Weatherford, OK. After completion of pharmacy school, Candace completed an ASHP-accredited PGY-1 residency from St. John Medical Center in Tulsa, OK. After residency, she has worked at UT Southwestern Medical Center in Dallas, TX in her role as a clinical staff pharmacist. She is double board certified in Pharmacotherapy (BCPS) and Geriatrics (BCGP) and her primary practice is with the Internal Medicine and Geriatrics teaching teams where she primarily precepts P4 students and PGY-1 residents on their Internal Medicine rotations. She also holds several leadership roles within her pharmacy department such as co-chair of Central Pharmacy Team and co-chair of the Pharmacy Preceptor Advisory Council. Her leadership roles within Phi Delta Chi include her collegiate tenure as the Worthy Prelate and Worthy Vice Counselor and as an alumnus she served as the Southcentral Regional Director of Collegiate Affairs (2019-2021).
Cassidy Hencley
Idaho State University College of Pharmacy
Cassidy Hencley is the current community-based pharmacy resident at Idaho State University. She graduated from Idaho State University with her PharmD in 2018 and worked in an advanced community pharmacy for two years prior to residency. Her interests are primary care, sustainable services and academia. Upon PGY1 residency graduation, she will be doing an ambulatory care PGY2 at Springfield Family Physicians where she can further develop skills as a pharmacist clinician.
Chloe Kent
Clinical Pharmacist at Cookeville Regional Medical Center
Dr. Kent is a graduate of Drake University in Des Moines, IA. She completed her PGY1 Pharmacy Residency at Cookeville Regional Medical Center in Cookeville, TN. She currently works as a clinical pharmacist at Cookeville Regional Medical Center with an interest in cardiology and critical care. During her collegiate tenure with Phi Delta Chi she served as the Chapter Publication Co-Chair, Worthy Master at Arms, Worthy Chief Counselor, and Midwest Regional Correspondent.
Chris Bollinger
Butler University
Chris Bollinger is a 4th year PharmD/MBA candidate from Butler University in Indianapolis, IN. Chris' past professional experiences include positions as a clinical inpatient pharmacy intern at Eskenazi Health and as a pharmacy intern at CVS Health, both in Indianapolis. In the summer of 2020, Chris participated as the Opioid Stewardship Intern at The Johns Hopkins Hospital Pharmacy Summer Internship in Baltimore, MD. Chris is hoping to pursue a clinical residency following graduation in pain/palliative medicine, ambulatory care, or infectious disease.
Chris Pavero
Chris Westrick
Christine Phan
PGY1 Community-Based Residency, Idaho State University
Christopher (Chris) Pavero
Clinical Pharmacy Coordinator, Cone Health Medical Group HeartCare
Dr. Pavero is Board Certified in Ambulatory Care Pharmacy and is a Certified Diabetes Educator. He is a graduate of Wingate University School of Pharmacy and completed a PGY1 Pharmacy Residency at Sun Life Family Health Center in Casa Grande, AZ. He is currently Clinical Pharmacy Coordinator at Cone Health Medical Group HeartCare in Greensboro, NC. He has served Phi Delta Chi as Mountain Region Director of Alumni Affairs since 2016.
Christopher (Chris) Westrick
Specialty Practice Pharmacist, Ambulatory Care, The Ohio State University Wexner Medical Center Department of Family and Community Medicine
Chris Westrick, PharmD, MPH, BCACP, CDCES, CTTS is a specialty practice pharmacist with the Department of Family and Community Medicine at THE Ohio State University Wexner Medical Center. He graduated with his Doctor of Pharmacy from the Ohio Northern University Raabe College of Pharmacy in 2011. He completed a PGY1 Pharmacy Practice Residency at Parkview Regional Medical (Fort Wayne, IN) and a PGY2 Ambulatory Care Specialty Practice Residency at the OSU Wexner Medical Center. After residency, he worked for the OSU College of Pharmacy experiential department practicing at local FQHCs before eventually joining the Department of Family and Community Medicine. Dr. Westrick is board certified in ambulatory care and also a certified diabetes care and education specialist as well as a certified tobacco treatment specialist. He graduated from the OSU College of Public Health with his MPH in 2018.
Currently, his time is split between Family Medicine at Outpatient Care East and Total Health and Wellness, a NP-led primary care practice with a focus on interdisciplinary team-based care and is currently the only FQHC within OSU. At each location, he provides clinical pharmacy services and chronic disease state education and management; and serves as the 340B program manager for Total Health and Wellness. With his expertise and passion for diabetes management, he serves on the Scarlet and Gray Way to Diabetes Self-Management Committee at OSU and annually updates the diabetes education and tobacco cessation education booklets used by the entire medical center.
A brother of the Alpha Upsilon Chapter, he currently serves as the faculty advisor for Xi and Regional Director for Alumni Affairs for the Great Lakes Region. He has also co-chaired and been an active member of several committees.
Col (Ret) John D. Grabenstein, PhD
Immunization Action Coalition, PLEI Chairman of the Board
John is general manager of Vaccine Dynamics and managing editor for the Immunization Action Coalition (IAC, immunize.org). He has published over 300 articles and eight books. As a Colonel in the U.S. Army, John directed the Military Vaccine Agency, where he organized “Immunization University.” He wrote the first curriculum for Leader-Development Seminars in 1989 and the first curriculum for “Pharmacy-Based Immunization Delivery” in 1996. He led global medical affairs for Merck Vaccines from 2006 to 2019. He received the Remington Honor Medal (2020), the ΦΛΣ National Leadership Award (2003, 2017), Rho Chi Society Lecture Award (2011), Gloria Francke Leadership Mentor Award (2006), ASHP Award for Sustained Contributions to the Literature (2006), AMSUS Andrew Craigie Award (2004), and the APhA/HCQA Pinnacle Award (1998).
Courtney Purcell
Craig Kimble
Associate Professor of Pharmacy Practice, Administration and Research; Director of Experiential Learning; Manager of Clinical Support Services; Marshall University School of Pharmacy
Craig is Associate Professor and Director of the Office of Experiential Learning at MUSOP. He serves as adjunct faculty with the MPH program at Marshall. Craig received a Doctor of Pharmacy degree from Ohio Northern University, a Master in Business Administration from Morehead State University, and a Master of Science in Healthcare Administration from Marshall. Craig completed an ASHP-accredited PGY1 residency in Pharmacy Practice at the University of Kentucky Hospitals and St. Claire Medical Center. Craig is a Board Certified Ambulatory Care Specialist (BCACP). Craig is also a Tobacco Treatment Specialist. Craig is recognized for service to the Community and Profession by winning the 2019 WVPA/APhA Foundation Bowl of Hygeia Award and the 2018 NCPA Leadership Award. He currently serves as the Director at Large for the West Virginia Pharmacists Association.
Daniel Winslow
David Nguyen
Staff Pharmacist, Medical Arts Pharmacy
Dena Dillion
Dimitrios (Dimitri) Savva
Clinical Pharmacy Specialist - Pediatric Critical Care at NewYork-Presbyterian Hospital / Morgan Stanley Children's Hospital
Dimitri Savva, PharmD, BCPPS was born and raised in Queens, NY where he received his Doctor of Pharmacy degree at St. John's University College of Pharmacy and Health Sciences in 2016. After graduation, he completed a PGY-1 Pharmacy Residency at Children’s National Health System in Washington, D.C and a PGY-2 Pediatric Pharmacy Residency at University of Maryland School of Pharmacy in Baltimore, Maryland. After completion of his PGY-2 year, he returned back home to New York City where he obtain his current role as a pediatric clinical pharmacy manager/specialist at Morgan Stanley Children's Hospital. His primary roles focuses in pediatric and neonatal critical care with specific interests in both pediatric/neonatal intensive care units, infant/pediatric cardiac intensive care units, step down units as well as has provided cross coverage in both pediatric and neonatal ICUs at NewYork-Presybterian Hospital /Komansky Children's Hospital. He was a active collegiate brother of the Beta Alpha Chapter of Phi Delta Chi since Spring 2011 and one of the founding members of the Beta Alpha Alumni Chapter in 2018. He current has served as the Northeast Regional Director of Collegiate Affairs since 2019.
Elizabeth Portteus
Emily Meggs
Emma Leffler
Eric Barbye
Eric Sorrell
Erin Resweber
Incoming PGY-1 Resident at Parkland Hospital in Dallas
Erin Resweber graduated from the University of Texas in 2020 amidst the COVID-19 pandemic. During her fourth-year rotations, her active-duty husband received orders for Germany which threw her plans for residency up in the air. With the uncertainty of the global pandemic, she chose to withdraw from the ASHP Match program to join her husband abroad for a year. While in Germany, Erin wrote a manuscript, continued her professional organization involvement, and became a Medical Professional Volunteer for the American Red Cross. With residency showcases and interviews being virtual, Erin was able to re-apply for the 2021-2022 residency cycle where she matched at her top choice, Parkland Health and Hospital System in Dallas, TX.
Erin Sherwin
PGY2 Ambulatory Care Resident, University of Kentucky HealthCare
Dr. Sherwin is a PGY2 Ambulatory Care resident at University of Kentucky HealthCare. She graduated from the University of Tennessee College of Pharmacy in 2020 before completing her PGY1 at the Birmingham VA Health Care System. As a student, she was an involved brother of Phi Delta Chi Omega chapter and served as Worthy Alumni Liaison. Her interests in ambulatory care include primary care, population health, cardiology and neurology. After residency, she hopes practice in one of these areas in addition to precepting and teaching.
Ethan Rawl
Student at Northeastern University
Ethan Rawl is a P4 student at Northeastern University, currently completing his rotation at Margolis Pharmacy, a local independent pharmacy. He has conducted research on positive allosteric modulation on cannabinoid receptors with Dr. Ganesh Thakur's lab. As a didactic student, he worked at Brigham and Women's Hospital, Inman Pharmacy, and Amgen. In the fall of 2015, he was initiated into the Beta Chi Chapter, where he has served as the chair of multiple committees, Worthy Keeper of Finance, Northeast Regional Correspondent, and now Assistant to the GVPCA. After graduating, he is considering going into industry pharmacy, although he is keeping his options open. In his free time, he enjoys working out, spending time with his two cats, and reconnecting with friends he has not seen in over a year due to the pandemic.
Gary Redfeather, PhD
DeMontfort University
Dr. Gary Redfeather received his pharmacy degree from the University of Wyoming (US) in 1990, his PhD in neuropharmacology from Oregon State University in 1995, and completed a post-doctoral fellowship in neurophysiology at the University of Toronto in 1997. His 30+ year career has focused on the adaptive and maladaptive neuroplastic changes that happen in chronic pain states and, by extension, how individuals and organizations deal with stress and trauma. He has developed and facilitated leader-development programs in the US since the mid-1990’s, activities that continue to complement the Clinical Leadership, Educational & Research program he leads in the School of Pharmacy at DeMontfort University in Leicester, United Kingdom.
Grant Stimes
Clinical Pharmacy Specialist at Texas Children's Hospital
Grant Stimes grew up in Geneseo, Illinois. After graduating high school, Grant attended Drake University in Des Moines, Iowa where he earned his Doctor of Pharmacy and Masters of Public Administration in May 2017. Grant then moved to Iowa City where he completed his Postgraduate (PGY1) Pharmacy Residency at the University of Iowa Hospitals and Clinics in June 2018. After completion of that program, Grant completed his PGY2 residency in Infectious Diseases through the University of Connecticut and Connecticut Children's Medical Center in 2019. Since 2019, Grant has lived in Houston, Texas and is an Antimicrobial Stewardship/Infectious Diseases Clinical Pharmacy Specialist at Texas Children's Hospital
Jacob Addams
CFO @ BlueSea
As an executive vice president and chief financial officer (CFO), Jacob is responsible for all of the company’s financial functions including accounting, audit, treasury, corporate finance and investor relations. His career spans more than 25 years of varied experience in financial management, business leadership and corporate strategy.
Jacob D. Northrup
Staff Pharmacist, Medical Arts Pharmacy
Jacob D. Northrup, PharmD, CDCES is a 2015 graduate of the D'Youville College School of Pharmacy in Buffalo, NY. Since 2019, he has worked as a clinical pharmacist with Sun Life Family Health Center (SLFHC) in Pinal County, AZ where he helped to create the multidisciplinary Medication Assisted Treatment Program. In addition to bringing knowledge of Pain Management practices to SLFHC, he is a Certified Diabetes Care and Education Specialist who has established clinical pharmacy services at two outyling sites that previously had none. Jacob is passionate about empowering patients to manage their pain and other chronic disease states as well as their substance use disorders.
Jalen Meek
President @ Vix Association
Jalen is a mexican technology entrepreneur and philanthropist who is known for co-founding and leading Vix Association.
James Winslow
James Winslow
Jennifer MacDonald
Oncology Pharmacy Clinical Specialist
Jennifer MacDonald, PharmD, BCOP is a clinical oncology pharmacy specialist at the Medical University of South Carolina and an Associate Professor at the School of Pharmacy. Jennifer graduated magna cum laude from South Carolina College of Pharmacy. After completion of pharmacy school, she completed her PGY1 and PGY2 Oncology Residency at the University of Colorado in Aurora, Colorado.
Jennifer currently serves as a specialist in gynecologic oncology at MUSC where she focuses her practice on advancing care for patients with cancer through improvements in supportive care and quality of life outcomes. She also serves as PGY2 Oncology Pharmacy Practice Residency Program Director where she loves working closely with residents and preparing them to change oncology practice standards for pharmacists across the country.
Jennifer Polyniak
Jerry Fu
Pharmacist in Charge at Southend Pharmacy, Founder/Owner of Adapting Leaders, LLC
Jerry Fu is a pharmacist and leadership coach. Getting fired was the wakeup call he needed to realize the urgency of improving himself as a leader. Once he helped facilitate a national Leader Development Seminar with PLEI in 2012, he grew confident enough in his leadership abilities to become a Pharmacist in Charge with his then-employer. That decision saved his career, because his leadership experience opened up work opportunities he wouldn’t otherwise have been considered for. He has since become a leadership coach to help others in the same way friends helped him, becoming a certified leadership coach through the International Coaching Federation. He now offers one-on-one coaching and group workshops, covering topics such as fighting apathy and leading without titles.
Jessica Papke
Clinical Assistant Professor of Pharmacy Practice at the University of Wyoming
I was born and raised in Denver, Colorado. I attended the University of Wyoming for pre-pharmacy and pharmacy school. After school, I completed a PGY1 in Pharmacy Practice at Memorial Hospital of South Bend in South Bend, Indiana. Upon completion of my residency, I accepted a position as a clinical pharmacist with an emphasis in transitions-of-care at Wyoming Medical Center in Casper, Wyoming. During my time as a clinical pharmacist, I continued to be involved with pharmacy residents by precepting internal medicine and cardiology rotations. Having a true desire to teach, I finally got my dream job as a Clinical Assistant Professor at my alma mater. I was able to continue to practice at Wyoming Medical Center and now work alongside the Wyoming Family Practice Residents.
JJ Lee
Josh Murdock
Joshua Caballero, PharmD, BCPP, FCCP
Professor and Chair, Department of Clinical and Administrative Sciences, College of Pharmacy, Larkin University
|
During his time in academia, Dr. Caballero served as the Chair, Vice-Chair, and Director of Fellowship Programs. He has received funding and published in areas focused on underserved populations. Dr. Caballero is known in the field of pharmacy as the primary editor for ASHP’s Get The Residency: ASHP's Guide to Residency Interviews and Preparation and has published and presented nationally in this area. He is a recipient of the Phi Delta Chi, Distinguished Alumni Award. |
JT Simonsen
Julia Olson
Katy Armstrong
Kenny Walkup
Kevin Bozymski
Assistant Professor of Clinical Sciences, Medical College of Wisconsin School of Pharmacy
Dr. Kevin Bozymski is an Assistant Professor at the Medical College of Wisconsin School of Pharmacy. He graduated with a PharmD from Butler University College of Pharmacy and Health Sciences, followed by post-graduate residency training at Eskenazi Health and Virginia Commonwealth University Health System. As a Board Certified Psychiatric Pharmacist, Dr. Bozymski practices and teaches students at both an adult psychiatry clinic and on an inpatient adult psychiatry unit. He is also a certified Mental Health First Aid instructor that hopes to reduce the stigma around discussing mental health concerns. Dr. Bozymski was an Alpha Phi collegiate brother and has served Phi Delta Chi in a variety of capacities, including chair of the national Workshop Revision Committee, a collegiate chapter evaluator, and a founding brother and now secretary of the Indiana Alumni Chapter.
Kirk Hevener
Assistant Professor of Pharmaceutical Sciences, University of Tennessee Health Science Center, Colloge of Pharmacy
Dr. Kirk Hevener is an Assistant Professor of Pharmaceutical Sciences at the University of Tennessee Health Science Center, College of Pharmacy. He graduated with a PharmD and PhD (medicinal chemistry) from UTHSC in 2005/2008. He completed postdoctoral research fellowships at St. Jude Children's Research Hospital and the Univeristy of Illinois at Chicago. He was a junior faculty member at Idaho State University College of Pharmacy (2013-2017) prior to his return to UTHSC College of Pharmacy. Dr. Hevener teaches medicinal chemistry in the PharmD and PhD progams at UTHSC and runs an active research laboratory, focusing on antibacterial target validation and pre-clinical infectious diseases drug discovery. He has published over 40 peer-reviewed manuscripts, book chapters, and abstracts and has received more than $2 million in extramural grant funding. He is an active member of Phi Delta Chi, the American Association for the Advancement of Science, the Society of Infectious Disease Pharmacists, the American Society for Microbiology, the American Chemical Society, and the American Association of College of Pharmacy. His is an ordained minister and has officiated the weddings of two PDC couples (including the Grand President's). In his free time he can be found pwning noobs on Xbox Live under the gamer tag 'Toxic Effects'.
Kirk Hevener
Assistant Professor of Pharmaceutical Sciences, University of Tennessee Health Science Center, Colloge of Pharmacy
Dr. Kirk Hevener is an Assistant Professor of Pharmaceutical Sciences at the University of Tennessee Health Science Center, College of Pharmacy. He graduated with a PharmD and PhD (medicinal chemistry) from UTHSC in 2005/2008. He completed postdoctoral research fellowships at St. Jude Children's Research Hospital and the Univeristy of Illinois at Chicago. He was a junior faculty member at Idaho State University College of Pharmacy (2013-2017) prior to his return to UTHSC College of Pharmacy. Dr. Hevener teaches medicinal chemistry in the PharmD and PhD progams at UTHSC and runs an active research laboratory, focusing on antibacterial target validation and pre-clinical infectious diseases drug discovery. He has published over 40 peer-reviewed manuscripts, book chapters, and abstracts and has received more than $2 million in extramural grant funding. He is an active member of Phi Delta Chi, the American Association for the Advancement of Science, the Society of Infectious Disease Pharmacists, the American Society for Microbiology, the American Chemical Society, and the American Association of College of Pharmacy. His is an ordained minister and has officiated the weddings of two PDC couples (including the Grand President's). In his free time he can be found pwning noobs on Xbox Live under the gamer tag 'Toxic Effects'.
Krishna Shah
Lacy La Fever
Doctor of Pharmacy Candidate-Third Year at Wingate University School of Pharmacy
Lacy La Fever is a current Third Year Pharmacy student at Wingate University School of Pharmacy. Besides being a Doctor of Pharmacy Candidate, she also has her BS in Biochemistry, MS in Biomedical Sciences, and is currently finishing up her hours for a Clinical Research Certificate through Cabarrus College. Her ultimate goal is to become a specialized pharmacist in Diabetes. Lacy is very passionate about educating her community to help prosper their knowledge and help lead them to be better leaders of their own health. Lacy currently works for Publix Pharmacy as a student intern. Besides work and school, Lacy has a fur baby named Polly who is a 13 year-old parti-colored standard poodle. If she could be anything other than a Pharmacist she would be a food and movie critic.
Landon Weaver
Lauren Marcath
Assistant Professor, Department of Pharmacotherapy, Washington State University
Dr. Marcath originally hails from southeast Michigan where she attended the University of Michigan for her undergraduate studies and then her Doctor of Pharmacy from the University of Michigan College of Pharmacy. Post-graduation she completed an academic fellowship at the University of Michigan focusing on pharmacogenomics and drug-drug interactions. She joined the faculty at Washington State University in the Department of Pharmacotherapy in 2019 where she teaches in a variety of courses including clinical pharmacogenomics, health care systems and patient safety. Dr. Marcath was initiated into the Alpha chapter as a pharmacy student at the University of Michigan and later served on their executive board. She currently serves as the faculty advisor for the Gamma Psi chapter at Washington State.
Lindsey Alison
Marketing manager @PicsNE
Lindsey holds ultimate responsibility for the organisations marketing activities and oversees the development and delivery of a fully integrated marketing strategy for the business. She also develops and implements PicsNE’s brand strategy.
Lori Carey
Madison Williams
Web Designer @ EvTI
Madison is a web designer who takes creative entrepreneurs from experiencing total tech confusion to feeling confident and relaxed about their online presence. She has been helping EvTI get the beautiful, functional websites they need to attract the quality leads and customers they want.
Margo Whitehead
Student Pharmacist, Butler University
Margo Whitehead is a fourth-year professional pharmacy student at Butler University College of Pharmacy and Health Sciences. During her years in pharmacy school, she has been actively involved in Phi Delta Chi and served as the School Visits Committee Head during the 2019-2020 school year. She also served on the executive board for APhA-ASP, serving as a Patient Care Vice President, President Elect, and President. She is also actively involved in Phi Lambda Sigma as the former secretary and now serves in the School Visits Executive Position. Margo is passionate about patient care and currently works at Walgreens as a pharmacy intern. She is also passionate about pharmacy education and enjoys pursuing educational topics through research.
Maria Garcia
CTO @ Learnyt
Maria Garcia is chief technology officer (CTO) and she brings extensive experience and passion to the role of CTO, where she is leading the development of new product pipelines, securing government funding for key strategic projects and building a world-class team to maintain the company’s technology leadership in the industries.
Matthew Thaller
Through 6/30: PGY1 Pharmacy Resident at The Hospital of Central Connecticut
Starting 7/5: PGY2 in Critical Care at Beth Israel Deaconess Medical Center
Matt is a graduate of St. John’s University – College of Pharmacy and Health Sciences. He completed a PGY1 Pharmacy Practice Residency at The Hospital of Central Connecticut in June, 2021 and is currently a PGY2 Resident in Critical Care at Beth Israel Deaconess Medical Center in Boston. He remains active in Phi Delta Chi on the Northeast Regional Team as Northeast Regional Director of Communications, as well as working closely with his collegiate chapter, Beta Alpha. While a collegiate, he served as Worthy Vice Counselor and Worthy Alumni Liaison, as well as several chair positions.
Matthew Thaller
Through 6/30: PGY1 Pharmacy Resident at The Hospital of Central Connecticut
Starting 7/5: PGY2 in Critical Care at Beth Israel Deaconess Medical Center
Matt is a graduate of St. John’s University – College of Pharmacy and Health Sciences. He completed a PGY1 Pharmacy Practice Residency at The Hospital of Central Connecticut in June, 2021 and is currently a PGY2 Resident in Critical Care at Beth Israel Deaconess Medical Center in Boston. He remains active in Phi Delta Chi on the Northeast Regional Team as Northeast Regional Director of Communications, as well as working closely with his collegiate chapter, Beta Alpha. While a collegiate, he served as Worthy Vice Counselor and Worthy Alumni Liaison, as well as several chair positions.
Michael Negrete, PharmD
Samuel Merritt University
Michael is assistant academic vice president at Samuel Merritt University in Oakland, CA. Previously, he served as vice president for clinical & educational affairs for the California Pharmacists Association (2012-2013) and chief executive officer for Pharmacy Foundation of California (2006-2011). Michael received the Prescott Pharmacy Leadership Award in 2006. He led the effort for the Leader-Development Institute offered by CPhA and APhA’s Lead360 leadership curriculum.
Michelle Le
Intern Pharmacist, Chapman University School of Pharmacy
Michelle Le is a current Pharm.D. student at the Chapman University School of Pharmacy expected to graduate in 2022. After a few years of working in the research laboratory, she challenged herself with an independent research project under the guidance of her faculty mentors. Her work focuses on exploring the increasing use of smartphone applications to help with health decisions regarding shared clinical decision-making vaccines.
Nancy A. Alvarez, PharmD, BCPS, CPCC
The University of Arizona College of Pharmacy – Phoenix Campus
Nicole (Haebig) Weinfurter
Peg Carver
Associate Professor of Pharmacy in the Department of Clinical Sciences at the College of Pharmacy, and a Clinical Pharmacist in Infectious Diseases at Michigan Medicine in Ann Arbor, Michigan
Peggy Carver, Pharm.D., FCCP, FIDP is an Associate Professor of Pharmacy in the Department of Clinical Sciences at the College of Pharmacy, and a Clinical Pharmacist in Infectious Diseases at Michigan Medicine in Ann Arbor, Michigan.
After completing her undergraduate degree in Biology at UCLA, she earned her Doctor of Pharmacy degree and served a residency at the University of California San Francisco School of Pharmacy, followed by fellowship in Infectious Diseases at Hartford Hospital in Hartford, Connecticut. Since then, she has practiced at Michigan Medicine with a specific expertise in fungal infections. Her research focuses on risk factors for the development of fungal infections and the role of metal ions in the development of infectious diseases. She is a proud graduate brother of Alpha Chapter since 2008, and the Chapter Advisor since 2009.
Peter Ryan
Quintin Broussard
Assistant Professor of Clinical Sciences and Medication Therapy Outcomes (MTO) Certificate Coordinator at Keck Graduate Institute School of Pharmacy and Health Sciences
Dr. Quintin Broussard received his Doctor of Pharmacy degree from the University of Houston College of Pharmacy. After graduating from the University of Houston, Dr. Broussard completed a PGY1 Pharmacy Practice Residency and a PGY2 Critical Care Pharmacy Residency at Baylor St. Luke’s Medical Center in Houston, TX, within the Texas Medical Center. He is board certified by the Board of Pharmacy Specialties in Pharmacotherapy, Critical Care, and Nutrition Support. Dr. Broussard is currently an Assistant Professor of Clinical Sciences at Keck Graduate Insitute School of Pharmacy and Health Sciences. During his time as a faculty member, Dr. Broussard has been honored as Faculty Preceptor of the Year, P3 Teacher of the Year, and Course Director for the P3 Course of the Year. He is currently involved in multiple organizations, including Phi Delta Chi as Pacific Regional Director for Collegiate Affairs, and as a member of the Self Assessment Committee and Nutrition Science & Practice Conference Monitoring Committee for ASPEN. Clinically, Dr. Broussard practices at San Antonio Regional Hospital in Critical Care and Nutrition Support. His practice interests include management of sepsis/septic shock, parenteral nutrition, and fluid/electrolyte disorders. Dr. Broussard's research interests include evaluation of parenteral nutrition prescribing patterns and outcomes, incorporation of nutrition support education into didactic Doctor of Pharmacy curricula, APPE readiness, and development and assessment of objective structured clinical examinations and clinical skills.
Rachel Whitesitt
Rachel Whitesitt
Ralph Reyes
Rhonda Cooper-DeHoff
Associate Professor, University of Florida, College of Pharmacy and Medicine
Rhonda M. Cooper-DeHoff, Pharm.D., M.S., is an associate professor, Department of Pharmacotherapy and Translational Research; and the Associate Director, Center for Pharmacogenomics and Precision Medicine. She is a graduate of the University of California, San Francisco School of Pharmacy. Dr. Cooper-DeHoff’s area of research interest include hypertension pharmacogenetics and the factors that influence outcomes with antihypertensive treatment. She also has interest in the area of antihypertensive drug use and adverse metabolic effects including diabetes, as well as the area of dietary supplements. In total, she has over 200 publications and many have been of high impact, helping to define demographic, clinical, metabolic, metabolomic and genetic and pharmacogenetic factors associated with responses to antihypertensive drugs and cardiovascular outcomes with antihypertensive therapy. She is currently conducting research in the area of preemptive pharmacogenetics testing in multiple therapeutic areas.
Robert Smith
Vice President of Operations @ WXCH
As executive vice president and chief operating officer, he is responsible for the global operations of the company. He brings more than 25 years of experience to WXCH
Sara Leazer
Southwestern Oklahoma State University College of Pharmacy
Sara is a third year pharmacy student at Southwestern Oklahoma State University where she was initiated into the Alpha Omega chapter in 2020. She has served her chapter as the Worthy Inner Guard and is the current Worthy Prelate for her chapter.
Shanna O'Connor
Idaho State University College of Pharmacy
Shanna K. O'Connor, PharmD, BCACP is an assistant professor at Idaho State University College of Pharmacy. She serves as Lead Network Facilitator for CPESN-ID and Residency Program Director for ISU's PGY1 Community-based Residency program. As a passionate advocate for sustainable services delivered by community pharmacists, her professional service and scholarship center around exploring and demonstrating reimbursement mechanisms for community pharmacist-delivered clinical services.
Tevin Johnson
Tony Mitchum
Traci Thompson
Traci Thompson
Tracy Peng
Tyler Prickette
Clinical Pharmacist, Forth HealthCare.
Victor Phan
Assistant Professor: California Northstate University College of Pharmacy/Ambulatory Care Pharmacist at Wellspace Health
Dr. Phan is a graduate of Temple University School of Pharmacy. He completed a PGY-1 Community Pharmacy Residency with ACME/Temple University School of Pharmacy and now works as a clinical faculty at the California Northstate University College of Pharmacy with an ambulatory care practice site at Wellspace Health for chronic disease state management under collaborative practice. Dr. Phan is board certified in ambulatory care, is a certified diabetes care and education specialist, and an advanced pharmacist practitioner.
Yancey Lockhart
Zoe Jo Kasten
Zoe Jo Kasten
Download InEvent App
Agenda
27
No activities available
28
No activities available
29
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:00 AM
- 11:30 PM
10:30 AM
- 11:30 PM
3:45 PM
- 5:15 PM
3:45 PM
- 5:15 PM
3:45 PM
- 5:15 PM
3:45 PM
- 5:15 PM
3:45 PM
- 5:15 PM
3:45 PM
- 5:15 PM
3:45 PM
- 5:15 PM
3:45 PM
- 5:15 PM
7:00 PM
- 8:30 PM
When finished viewing the pre-recorded session, please click here to view Q&A Session
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality globally. Heart failure impacts more than six million Americans. Regardless of practice setting, most pharmacists are involved in the care of patients at risk for ASCVD and/or living with heart failure. In addition to diet and lifestyle modifications, medications remain the backbone of preventive and treatment strategies for these disease states. The purpose of this application-based activity is to review the newest guidelines related to ASCVD primary prevention (2019) and heart failure (2021), and apply them to patient cases.
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality globally. Heart failure impacts more than six million Americans. Regardless of practice setting, most pharmacists are involved in the care of patients at risk for ASCVD and/or living with heart failure. In addition to diet and lifestyle modifications, medications remain the backbone of preventive and treatment strategies for these disease states. The purpose of this application-based activity is to review the newest guidelines related to ASCVD primary prevention (2019) and heart failure (2021), and apply them to patient cases.
When finished viewing the pre-recorded session, please click here to view Q&A Session
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality globally. Heart failure impacts more than six million Americans. Regardless of practice setting, most pharmacists are involved in the care of patients at risk for ASCVD and/or living with heart failure. In addition to diet and lifestyle modifications, medications remain the backbone of preventive and treatment strategies for these disease states. The purpose of this application-based activity is to review the newest guidelines related to ASCVD primary prevention (2019) and heart failure (2021), and apply them to patient cases.
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality globally. Heart failure impacts more than six million Americans. Regardless of practice setting, most pharmacists are involved in the care of patients at risk for ASCVD and/or living with heart failure. In addition to diet and lifestyle modifications, medications remain the backbone of preventive and treatment strategies for these disease states. The purpose of this application-based activity is to review the newest guidelines related to ASCVD primary prevention (2019) and heart failure (2021), and apply them to patient cases.
7:00 PM
- 8:30 PM
Hundreds of thousands of pharmacists have moved through traditional paths and may benefit from guidance on moving to a non-traditional role. Pharmacists have opportunities to develop entrepreneurship practices outside of traditional models through various solo and collaborative entrepreneurial ventures, but there is little research as to which knowledge, skills and attitudes (KSAs) are most important for pharmacist entrepreneurs. The literature identifies risk-taking, creativity/innovation, and social responsibility as important traits. By reviewing the paths of pharmacists who have made the transition from traditional roles to entrepreneurial non-traditional roles using these traits we can learn how to develop more pharmacists moving into novel spaces to impact patients and other health professionals. The purpose of this knowledge-based activity is to review the entrepreneurial routes available and the effectiveness of pharmacists in these roles as opportunities to further impact patients and professionals.
Following the pre-recorded session there will be a live Q&A, click here to access.
Following the pre-recorded session there will be a live Q&A, click here to access.
Hundreds of thousands of pharmacists have moved through traditional paths and may benefit from guidance on moving to a non-traditional role. Pharmacists have opportunities to develop entrepreneurship practices outside of traditional models through various solo and collaborative entrepreneurial ventures, but there is little research as to which knowledge, skills and attitudes (KSAs) are most important for pharmacist entrepreneurs. The literature identifies risk-taking, creativity/innovation, and social responsibility as important traits. By reviewing the paths of pharmacists who have made the transition from traditional roles to entrepreneurial non-traditional roles using these traits we can learn how to develop more pharmacists moving into novel spaces to impact patients and other health professionals. The purpose of this knowledge-based activity is to review the entrepreneurial routes available and the effectiveness of pharmacists in these roles as opportunities to further impact patients and professionals.
Following the pre-recorded session there will be a live Q&A, click here to access.
Following the pre-recorded session there will be a live Q&A, click here to access.
7:45 PM
- 8:25 PM
7:45 PM
- 8:25 PM
8:00 PM
- 11:30 PM
9:00 PM
- 10:05 PM
30
10:30 AM
- 11:30 PM
2:30 PM
- 5:30 PM
2:30 PM
- 5:30 PM
2:30 PM
- 5:30 PM
2:30 PM
- 5:30 PM
2:30 PM
- 5:30 PM
2:30 PM
- 5:30 PM
2:30 PM
- 5:30 PM
2:30 PM
- 5:30 PM
5:00 PM
- 7:00 PM
When finished viewing the pre-recorded session, please click here to view Q&A Session.
Millions of Americans are affected, either directly or indirectly, by diabetes mellitus. Standard of practice for those requiring insulin may include multiple daily injections and/or multiple incidences of fingersticks to monitor blood glucose. Diabetes technology has expanded to include hybrid devices that monitor glucose and deliver insulin, as well as software that provides diabetes self-management support. These advances in diabetes technology have the potential to improve quality life and quality of care. The purpose of this knowledge-based activity is to review recent advances in diabetes technology, including insulin pumps and continuous glucose monitors, and their effectiveness as well as barriers to implementation.
Millions of Americans are affected, either directly or indirectly, by diabetes mellitus. Standard of practice for those requiring insulin may include multiple daily injections and/or multiple incidences of fingersticks to monitor blood glucose. Diabetes technology has expanded to include hybrid devices that monitor glucose and deliver insulin, as well as software that provides diabetes self-management support. These advances in diabetes technology have the potential to improve quality life and quality of care. The purpose of this knowledge-based activity is to review recent advances in diabetes technology, including insulin pumps and continuous glucose monitors, and their effectiveness as well as barriers to implementation.
When finished viewing the pre-recorded session, please click here to view Q&A Session.
Millions of Americans are affected, either directly or indirectly, by diabetes mellitus. Standard of practice for those requiring insulin may include multiple daily injections and/or multiple incidences of fingersticks to monitor blood glucose. Diabetes technology has expanded to include hybrid devices that monitor glucose and deliver insulin, as well as software that provides diabetes self-management support. These advances in diabetes technology have the potential to improve quality life and quality of care. The purpose of this knowledge-based activity is to review recent advances in diabetes technology, including insulin pumps and continuous glucose monitors, and their effectiveness as well as barriers to implementation.
Millions of Americans are affected, either directly or indirectly, by diabetes mellitus. Standard of practice for those requiring insulin may include multiple daily injections and/or multiple incidences of fingersticks to monitor blood glucose. Diabetes technology has expanded to include hybrid devices that monitor glucose and deliver insulin, as well as software that provides diabetes self-management support. These advances in diabetes technology have the potential to improve quality life and quality of care. The purpose of this knowledge-based activity is to review recent advances in diabetes technology, including insulin pumps and continuous glucose monitors, and their effectiveness as well as barriers to implementation.
5:00 PM
- 7:00 PM
5:00 PM
- 7:00 PM
Throughout the past century, we have developed the science and technology to address vaccine-preventable diseases. In the midst of the global COVID-19 pandemic, effectively conveying the importance of vaccinations to the public is of utmost importance. The Centers for Disease Control and Prevention (CDC) recommends immunization schedules depending on age and patient-specific factors. These schedules are updated as new evidence and studies are released. Not only have there been updates to the immunization schedule in recent years, but there are also many considerations that come with the new SARS-CoV-2 vaccines authorized for use and under investigation. The purpose of this application-based activity is to review updates in immunizations and recommendations.
Following the pre-recorded session there will be a live Q&A, click here to access.
Following the pre-recorded session there will be a live Q&A, click here to access.
Throughout the past century, we have developed the science and technology to address vaccine-preventable diseases. In the midst of the global COVID-19 pandemic, effectively conveying the importance of vaccinations to the public is of utmost importance. The Centers for Disease Control and Prevention (CDC) recommends immunization schedules depending on age and patient-specific factors. These schedules are updated as new evidence and studies are released. Not only have there been updates to the immunization schedule in recent years, but there are also many considerations that come with the new SARS-CoV-2 vaccines authorized for use and under investigation. The purpose of this application-based activity is to review updates in immunizations and recommendations.
Following the pre-recorded session there will be a live Q&A, click here to access.
Following the pre-recorded session there will be a live Q&A, click here to access.
5:00 PM
- 7:00 PM
5:00 PM
- 7:00 PM
Both COVID-19 and refractory shock ae prevalent; however, evidence regarding COVID-19 and refractory shock treatments varies. Many treatment options for COVID-19 and shock exist which are cited in guidelines and recommendations. The purpose of this knowledge-based activity is to identify treatment options for COVID-19 and refractory shock and discuss literature regarding their usage.
Following pre-recorded session, there will be a live Q&A. Click here to access.
Following pre-recorded session, there will be a live Q&A. Click here to access.
Both COVID-19 and refractory shock ae prevalent; however, evidence regarding COVID-19 and refractory shock treatments varies. Many treatment options for COVID-19 and shock exist which are cited in guidelines and recommendations. The purpose of this knowledge-based activity is to identify treatment options for COVID-19 and refractory shock and discuss literature regarding their usage.
Following pre-recorded session, there will be a live Q&A. Click here to access.
Following pre-recorded session, there will be a live Q&A. Click here to access.
5:00 PM
- 7:00 PM
5:00 PM
- 8:15 PM
5:00 PM
- 8:15 PM
8:00 PM
- 11:30 PM
31
8:00 AM
- 11:45 PM
9:30 AM
- 11:30 AM
Diabetic ketoacidosis is a common disease state that drains healthcare resources and creates a significant financial impact on health systems and patients. The current guideline recommendation for management is an IV bolus of regular insulin followed by a continuous insulin infusion therapy. More recent evidence-based data have showed that the introduction of long-acting insulin may result in enhanced efficacy and improved safety of management. The purpose of this application-based activity is to review the pharmacodynamic and pharmacokinetic aspects of long-acting insulin that may be beneficial in treating this disease state and to apply this knowledge to the creation and implementation of an evidence-based protocol using this knowledge.
Preexisting and gestational diabetes are increasing in women of reproductive age in America. The presence of all forms of diabetes increases risk to both the mother and the fetus. While current pharmacy practice and education focus on managing type 1 and type 2 diabetes, there is a considerable gap in the literature on the role of pharmacists in managing and treating patients with gestational diabetes. As the patient's most accessible healthcare provider, pharmacists have a unique role in education, prevention, and treatment of gestational diabetes and therefore reduce the possibility of pregnancy related complications such as spontaneous abortion, preeclampsia, macrosomia, and fetal abnormalities. The purpose of this application-based activity is to educate the pharmacist in understanding the pathophysiology of gestational diabetes, define the diagnostic criteria of gestational diabetes, and apply appropriate pharmacologic and nonpharmacologic treatment for gestational diabetes.
Following the pre-recorded session there will be a live Q&A, click here to access.
Preexisting and gestational diabetes are increasing in women of reproductive age in America. The presence of all forms of diabetes increases risk to both the mother and the fetus. While current pharmacy practice and education focus on managing type 1 and type 2 diabetes, there is a considerable gap in the literature on the role of pharmacists in managing and treating patients with gestational diabetes. As the patient's most accessible healthcare provider, pharmacists have a unique role in education, prevention, and treatment of gestational diabetes and therefore reduce the possibility of pregnancy related complications such as spontaneous abortion, preeclampsia, macrosomia, and fetal abnormalities. The purpose of this application-based activity is to educate the pharmacist in understanding the pathophysiology of gestational diabetes, define the diagnostic criteria of gestational diabetes, and apply appropriate pharmacologic and nonpharmacologic treatment for gestational diabetes.
Following the pre-recorded session there will be a live Q&A, click here to access.
Diabetic ketoacidosis is a common disease state that drains healthcare resources and creates a significant financial impact on health systems and patients. The current guideline recommendation for management is an IV bolus of regular insulin followed by a continuous insulin infusion therapy. More recent evidence-based data have showed that the introduction of long-acting insulin may result in enhanced efficacy and improved safety of management. The purpose of this application-based activity is to review the pharmacodynamic and pharmacokinetic aspects of long-acting insulin that may be beneficial in treating this disease state and to apply this knowledge to the creation and implementation of an evidence-based protocol using this knowledge.
Preexisting and gestational diabetes are increasing in women of reproductive age in America. The presence of all forms of diabetes increases risk to both the mother and the fetus. While current pharmacy practice and education focus on managing type 1 and type 2 diabetes, there is a considerable gap in the literature on the role of pharmacists in managing and treating patients with gestational diabetes. As the patient's most accessible healthcare provider, pharmacists have a unique role in education, prevention, and treatment of gestational diabetes and therefore reduce the possibility of pregnancy related complications such as spontaneous abortion, preeclampsia, macrosomia, and fetal abnormalities. The purpose of this application-based activity is to educate the pharmacist in understanding the pathophysiology of gestational diabetes, define the diagnostic criteria of gestational diabetes, and apply appropriate pharmacologic and nonpharmacologic treatment for gestational diabetes.
Following the pre-recorded session there will be a live Q&A, click here to access.
Preexisting and gestational diabetes are increasing in women of reproductive age in America. The presence of all forms of diabetes increases risk to both the mother and the fetus. While current pharmacy practice and education focus on managing type 1 and type 2 diabetes, there is a considerable gap in the literature on the role of pharmacists in managing and treating patients with gestational diabetes. As the patient's most accessible healthcare provider, pharmacists have a unique role in education, prevention, and treatment of gestational diabetes and therefore reduce the possibility of pregnancy related complications such as spontaneous abortion, preeclampsia, macrosomia, and fetal abnormalities. The purpose of this application-based activity is to educate the pharmacist in understanding the pathophysiology of gestational diabetes, define the diagnostic criteria of gestational diabetes, and apply appropriate pharmacologic and nonpharmacologic treatment for gestational diabetes.
Following the pre-recorded session there will be a live Q&A, click here to access.
9:30 AM
- 11:30 AM
9:30 AM
- 11:30 AM
When finished viewing the pre-recorded session, please click here to view Q&A Session.
Pathogenic bacteria continue to develop resistance to newly developed antibacterial agents at an alarming rate. This necessitates a steady pipeline of novel antibacterials with new mechanisms of action that can overcome bacterial resistance. The result of this microbiological stalemate is constantly evolving therapeutic treatment guidelines. Knowledge of newly published, evidence-based treatment guidelines for bacterial pathogens of concern, including MDR Gram-native organisms and anaerobic organisms, is crucial for pharmacists to effectively participate in the treatment of affected patients as members of the health-care team. The purpose of this knowledge-based activity is to review the latest treatment guidelines for bacterial pathogens that pose a critical threat (CDC Threat Report, 2019) including MDR Gram-negative organisms and C.difficlie and to introduce the learners to novel treatment options that are in late-stage discovery that are likely to enter clinical practice soon.
Pathogenic bacteria continue to develop resistance to newly developed antibacterial agents at an alarming rate. This necessitates a steady pipeline of novel antibacterials with new mechanisms of action that can overcome bacterial resistance. The result of this microbiological stalemate is constantly evolving therapeutic treatment guidelines. Knowledge of newly published, evidence-based treatment guidelines for bacterial pathogens of concern, including MDR Gram-native organisms and anaerobic organisms, is crucial for pharmacists to effectively participate in the treatment of affected patients as members of the health-care team. The purpose of this knowledge-based activity is to review the latest treatment guidelines for bacterial pathogens that pose a critical threat (CDC Threat Report, 2019) including MDR Gram-negative organisms and C.difficlie and to introduce the learners to novel treatment options that are in late-stage discovery that are likely to enter clinical practice soon.
When finished viewing the pre-recorded session, please click here to view Q&A Session.
Pathogenic bacteria continue to develop resistance to newly developed antibacterial agents at an alarming rate. This necessitates a steady pipeline of novel antibacterials with new mechanisms of action that can overcome bacterial resistance. The result of this microbiological stalemate is constantly evolving therapeutic treatment guidelines. Knowledge of newly published, evidence-based treatment guidelines for bacterial pathogens of concern, including MDR Gram-native organisms and anaerobic organisms, is crucial for pharmacists to effectively participate in the treatment of affected patients as members of the health-care team. The purpose of this knowledge-based activity is to review the latest treatment guidelines for bacterial pathogens that pose a critical threat (CDC Threat Report, 2019) including MDR Gram-negative organisms and C.difficlie and to introduce the learners to novel treatment options that are in late-stage discovery that are likely to enter clinical practice soon.
Pathogenic bacteria continue to develop resistance to newly developed antibacterial agents at an alarming rate. This necessitates a steady pipeline of novel antibacterials with new mechanisms of action that can overcome bacterial resistance. The result of this microbiological stalemate is constantly evolving therapeutic treatment guidelines. Knowledge of newly published, evidence-based treatment guidelines for bacterial pathogens of concern, including MDR Gram-native organisms and anaerobic organisms, is crucial for pharmacists to effectively participate in the treatment of affected patients as members of the health-care team. The purpose of this knowledge-based activity is to review the latest treatment guidelines for bacterial pathogens that pose a critical threat (CDC Threat Report, 2019) including MDR Gram-negative organisms and C.difficlie and to introduce the learners to novel treatment options that are in late-stage discovery that are likely to enter clinical practice soon.
9:30 AM
- 11:30 AM
9:30 AM
- 11:30 AM
When finished viewing the pre-recorded session, please click here to view Part 2.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
When finished viewing the pre-recorded session, please click here to view Part 2.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
9:30 AM
- 11:30 AM
When finished viewing the pre-recorded session, please click here to view Q&A Session.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
When finished viewing the pre-recorded session, please click here to view Q&A Session.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
With the ongoing opioid epidemic devastating many families over the past decade, millions of Americans are experiencing acute and chronic pain, but are now under scrutiny for utilizing opioid therapy or feel pressured to de-escalate their therapy. One way to educate the public about multimodal, collaborative pain therapy can be via pharmacists working in all healthcare settings but some may lack confidence recommending opioid conversions, proposing alternative pain treatments, or dispensing naloxone. The purpose of part one of this application-based activity is to review opioid conversions, no opioid options for treatment and other topics surrounding acute and chronic pain including naloxone provisioning.
Part two will review adjuvant therapies for pain management when conventional opioid and non-opioid therapies are inadequate for a patient, primarily in cancer patients. Many patients fail opioid therapies and need adjuvant therapies to better manage their pain, but it is often difficult to feel comfortable with these complex clinical scenarios. We will discuss the role for palliative care or pain management services and recommendations for how to initiate methadone, bisphosphonates, and pain pumps for patients. The aim of part two is to help pharmacists feel comfortable knowing when additional services may be necessary, what to look for when filling these prescriptions, and monitoring regimens for safety and efficacy.
9:30 AM
- 11:30 AM
9:30 AM
- 10:30 AM
11:00 AM
- 12:00 PM
11:45 AM
- 12:45 PM
Millions of people have at some point in their life or career felt that their success is one that was just earned by chance, one that they truly did not deserve. This feeling of self-doubt is also known as imposter syndrome. From student to professional, these moments can truly affect our mental and physical state of being. Yet when faced with chance to accept they look away not facing the truth. The purpose of this knowledge-based activity is to identify the meaning of imposter syndrome and its effects on students, new & seasoned practitioners, and discuss effective modalities to overcome it throughout all stages of life and career.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
Millions of people have at some point in their life or career felt that their success is one that was just earned by chance, one that they truly did not deserve. This feeling of self-doubt is also known as imposter syndrome. From student to professional, these moments can truly affect our mental and physical state of being. Yet when faced with chance to accept they look away not facing the truth. The purpose of this knowledge-based activity is to identify the meaning of imposter syndrome and its effects on students, new & seasoned practitioners, and discuss effective modalities to overcome it throughout all stages of life and career.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
11:45 AM
- 12:45 PM
11:45 AM
- 1:45 PM
Pharmacy preceptors assume the role of teacher, mentor, and evaluator by showing students how to apply knowledge learned from clincal courses to daily practice and to share knowledge and skills with them. They also must assess the students' performance through standardized evaluations to improve their strengths and correct their weaknesses. Although precepting learners is an important aspect of giving back to the profession, preceptors typically spend most of the time imparting clinical facts and pearls and devote less time to understanding strategies to improve their precepting style and adopting new teaching modalities to keep up with their own preceptor development. The purpose of this knowledge-based activity is to review different strategies and concepts for preceptors to use for specified student learners and rotations.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
Pharmacy preceptors assume the role of teacher, mentor, and evaluator by showing students how to apply knowledge learned from clincal courses to daily practice and to share knowledge and skills with them. They also must assess the students' performance through standardized evaluations to improve their strengths and correct their weaknesses. Although precepting learners is an important aspect of giving back to the profession, preceptors typically spend most of the time imparting clinical facts and pearls and devote less time to understanding strategies to improve their precepting style and adopting new teaching modalities to keep up with their own preceptor development. The purpose of this knowledge-based activity is to review different strategies and concepts for preceptors to use for specified student learners and rotations.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
Following the pre-recorded session, there will be a live Q&A. Click here to access.
11:45 AM
- 12:45 PM
12:30 PM
- 1:30 PM
12:45 PM
- 1:45 PM
When finished viewing the pre-recorded session, please Click here to view Q&A Session.
Polymorphisms impacting drug metabolism or action are common, which can impact therapy efficacy or toxicity. One such example is CYP2D6, a highly polymorphic gene, that encodes the CYP2D6 enzyme, which is responsible for the metabolism of many drugs. Uptake of utilizing pharmacogenomic guidelines into practice has been slow, and one barrier is lack of clinician understanding and comfortability with pharmacogenomics. The purpose of this knowledge-based activity is to review the importance of pharmacogenomics, the basics of pharmacogenomics, and available pharmacogenomic guidelines.
Polymorphisms impacting drug metabolism or action are common, which can impact therapy efficacy or toxicity. One such example is CYP2D6, a highly polymorphic gene, that encodes the CYP2D6 enzyme, which is responsible for the metabolism of many drugs. Uptake of utilizing pharmacogenomic guidelines into practice has been slow, and one barrier is lack of clinician understanding and comfortability with pharmacogenomics. The purpose of this knowledge-based activity is to review the importance of pharmacogenomics, the basics of pharmacogenomics, and available pharmacogenomic guidelines.
When finished viewing the pre-recorded session, please Click here to view Q&A Session.
Polymorphisms impacting drug metabolism or action are common, which can impact therapy efficacy or toxicity. One such example is CYP2D6, a highly polymorphic gene, that encodes the CYP2D6 enzyme, which is responsible for the metabolism of many drugs. Uptake of utilizing pharmacogenomic guidelines into practice has been slow, and one barrier is lack of clinician understanding and comfortability with pharmacogenomics. The purpose of this knowledge-based activity is to review the importance of pharmacogenomics, the basics of pharmacogenomics, and available pharmacogenomic guidelines.
Polymorphisms impacting drug metabolism or action are common, which can impact therapy efficacy or toxicity. One such example is CYP2D6, a highly polymorphic gene, that encodes the CYP2D6 enzyme, which is responsible for the metabolism of many drugs. Uptake of utilizing pharmacogenomic guidelines into practice has been slow, and one barrier is lack of clinician understanding and comfortability with pharmacogenomics. The purpose of this knowledge-based activity is to review the importance of pharmacogenomics, the basics of pharmacogenomics, and available pharmacogenomic guidelines.
12:45 PM
- 1:45 PM
12:45 PM
- 1:45 PM
When finished viewing the pre-recorded session, please click hereto view Q&A Session.
A clear need exists for sustainability in outpatient community pharmacy setting, but a sustained decline in PBM reimbursements (that are unlikely to be reversed) has resulted in pharmacy closures and a sever constriction on the profession. Creative approached to address this constriction are needed in order to maintain community pharmacy presence in the nation. This session will highlight the problem, identify opportunities, and build evaluation opportunities in participants. The workshop will facilitate the ability to create plans for new revenue streams.
A clear need exists for sustainability in outpatient community pharmacy setting, but a sustained decline in PBM reimbursements (that are unlikely to be reversed) has resulted in pharmacy closures and a sever constriction on the profession. Creative approached to address this constriction are needed in order to maintain community pharmacy presence in the nation. This session will highlight the problem, identify opportunities, and build evaluation opportunities in participants. The workshop will facilitate the ability to create plans for new revenue streams.
When finished viewing the pre-recorded session, please click hereto view Q&A Session.
A clear need exists for sustainability in outpatient community pharmacy setting, but a sustained decline in PBM reimbursements (that are unlikely to be reversed) has resulted in pharmacy closures and a sever constriction on the profession. Creative approached to address this constriction are needed in order to maintain community pharmacy presence in the nation. This session will highlight the problem, identify opportunities, and build evaluation opportunities in participants. The workshop will facilitate the ability to create plans for new revenue streams.
A clear need exists for sustainability in outpatient community pharmacy setting, but a sustained decline in PBM reimbursements (that are unlikely to be reversed) has resulted in pharmacy closures and a sever constriction on the profession. Creative approached to address this constriction are needed in order to maintain community pharmacy presence in the nation. This session will highlight the problem, identify opportunities, and build evaluation opportunities in participants. The workshop will facilitate the ability to create plans for new revenue streams.
12:45 PM
- 1:45 PM
12:45 PM
- 1:45 PM
1:30 PM
- 10:00 PM